(Q44103376)

29 November 2017

Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture (English)

1 reference

29 November 2017

3

1 reference

29 November 2017

4

David J Greenblatt

1 reference

29 November 2017

2

Lisa L von Moltke

1 reference

29 November 2017

1

Elke Störmer

1 reference

PubMed ID

12180537

29 November 2017

language of work or name

1 reference

1 July 2002

1 reference

29 November 2017

Pharmaceutical Research

1 reference

29 November 2017

19

1 reference

29 November 2017

7

1 reference

29 November 2017

1038-1045

1 reference

Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A

29 November 2017

1 reference

12 December 2020

Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.

1 reference

12 December 2020

Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

1 reference

12 December 2020

Multidrug-resistance phenotype in Chinese hamster ovary cells

1 reference

12 December 2020

Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells

1 reference

12 December 2020

Induction of P-glycoprotein expression by HIV protease inhibitors in cell culture.

1 reference

12 December 2020

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

1 reference

12 December 2020

Cell cultures as tools in biopharmacy.

1 reference

12 December 2020

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

12 December 2020

Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.

1 reference

12 December 2020

Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16

1 reference

12 December 2020

Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG).

1 reference

12 December 2020

Human colonic adenocarcinoma cells. I. Establishment and description of a new line

1 reference

12 December 2020

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

1 reference

12 December 2020

Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp).

1 reference

12 December 2020

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

12 December 2020

Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes

1 reference

12 December 2020

Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir

1 reference

12 December 2020

Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism

1 reference

12 December 2020

Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds

1 reference

12 December 2020

Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line

1 reference

12 December 2020

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

12 December 2020

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

12 December 2020

Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation

1 reference

12 December 2020

Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test

1 reference

12 December 2020

Coordinated regulation of P-glycoprotein activity and cytochrome P-4501A induction in sublines of rat hepatoma McA RH7777 cells with different levels of colchicine resistance

1 reference

12 December 2020

New antiretrovirals and new combinations.

1 reference

12 December 2020

Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

1 reference

12 December 2020

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

1 reference

12 December 2020

Multiple cytochrome P-450 subfamilies are co-induced with P-glycoprotein by both phenothiazine and 2-acetylaminofluorene in rats

1 reference

12 December 2020

Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.

1 reference

12 December 2020

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

1 reference

12 December 2020

1 reference

12 December 2020

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

12 December 2020

Caco-2 monolayers in experimental and theoretical predictions of drug transport

1 reference

12 December 2020

P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies

1 reference

12 December 2020

Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.

1 reference

12 December 2020

Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir.

1 reference

12 December 2020

Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.

1 reference

12 December 2020

Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016430825740

1 reference

29 November 2017

1 reference

PubMed ID

12180537